Table 2.
Preferred site for buprenorphine maintenance treatment (BMT) among clients of a NYC harm reduction agency (N = 73)a
| Sociodemographic Characteristics | WHCP (N = 49) N (%) |
Drug Tx Program (N = 11) N (%) |
General Medical Clinic (N = 13) N (%) |
|---|---|---|---|
|
| |||
| Age median (IQ range)a | 49 (39 – 53) | 47 (44 – 52) | 43 (38 – 46) |
| Male | 34 (69)* | 4 (36) | 13 (100) |
| Race/Ethnicity | |||
| Hispanic | 23 (47) | 5 (45) | 8 (62) |
| Non-Hispanic White | 18 (37) | 1 (9) | 3 (23) |
| Non-Hispanic Black | 6 (12) | 3 (27) | 2 (15) |
| Other | 1 (2) | 1 (9) | 0 (0) |
| Have Medicaid | 32 (65) | 7 (64) | 9 (69) |
| High School Graduate or GED | 39 (80)* | 5 (45) | 9 (69) |
| Employed | 6 (12) | 1 (9) | 3 (23) |
| Stable Housing | 16 (33) | 4 (36) | 3 (23) |
| History of incarceration | 40 (82) | 9 (82) | 11 (85) |
| History of injecting drug use | 42 (86)* | 5 (45) | 11 (85) |
| Current Substance Use (past 30 days) | |||
| Any Opioid | 49 (100) | 10 (91) | 13 (100) |
| Heroin | 43 (88) | 7 (64) | 11 (85) |
| Methadone | 27 (55) | 7 (64) | 7 (54) |
| Methadone program | 15 (29) | 6 (50) | 5 (38) |
| Opioid Analgesics | 23 (47) | 3 (27) | 6 (46) |
| Buprenorphine | 17 (35)* | 0 (0) | 5 (38) |
| Cocaine | 26 (53) | 7 (64) | 6 (46) |
| Amphetamine | 4 (8) | 0 (0) | 1 (8) |
| Sedatives/Benzodiazepines | 24 (49)** | 2 (18) | 4 (31) |
| Treatment History (ever) | |||
| Methadone Maintenance | 31 (63) | 8 (73) | 10 (77) |
| Prescribed Buprenorphine | 15 (31)** | 3 (27) | 8 (62) |
|
| |||
| Buprenorphine Variables | |||
| Overall Interest in BMT (mean ± SD) | 3.63 (± 1.02) | 3.18 (± 1.54) | 3.70 (± 0.82) |
| Interest in Harm Reduction Agencyb | 4.13 (± 0.82)* | 3.18 (± 1.25) | 3.90 (± 0.88) |
| Interest in General Medical Clinicb | 3.56 (± 1.01)* | 2.55 (± 1.29) | 3.70 (± 1.25) |
| Interest in Drug Treatment Programb | 3.25 (± 1.14) | 2.81 (± 1.54) | 3.70 (± 0.95) |
| Treatment Readiness | |||
| Motivation for treatment (mean ± SD)c | 11.76 (± 2.31) | 10.00 (± 3.66) | 11.31 (± 3.07) |
| Barriers to BMT | |||
| ≥ 1 barrier | 39 (80)* | 3 (27) | 8 (62) |
a
29 without preference (25 answered, “I would not choose to get treatment with Suboxone”; 4 unaware of buprenorphine)
b
N = 69
c
Scale out of 15
*
p < 0.05
**
p < 0.15 (three group comparisons: chi-square or ANOVA)